Inoviq Ltd Trading Halt Pending EXO-OC Test Results
Key points
- Inoviq Ltd requests a trading halt on its securities
- Halt pending announcement on EXO-OC test results
- Halt to remain until announcement or July 1, 2026
- No other market disclosures required at this time
Full summary
Inoviq Ltd (ASX: IIQ) has requested a trading halt on its securities until it announces the results of its EXO-OC test retrospective clinical study. The halt is in accordance with ASX listing rule 17.1. The trading halt will remain in effect until the earlier of the release of the announcement regarding the study results or the commencement of trading on Wednesday, July 1, 2026. The company does not anticipate any reason for the halt not to be granted and is not aware of any further information that needs to be disclosed to the market at this time.
Summary generated by a large language model. Please interpret with care.